Cargando…
Sinonasal hemangiopericytoma: A rare sinonasal tumor
Hemangiopericytoma is a rare vascular tumor arising from pericytes and occurs very rarely in sinonasal region. A 48-year-old man with sinonasal mass presented with nasal obstruction and occasional epistaxis. Nasal endoscopy showed a readily bleeding mass in the left nasal cavity. Endoscopic removal...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240854/ https://www.ncbi.nlm.nih.gov/pubmed/37284225 http://dx.doi.org/10.1177/2050313X231173787 |
_version_ | 1785053867285676032 |
---|---|
author | Pokharel, Apar Rai, Sabina Baral, Alina |
author_facet | Pokharel, Apar Rai, Sabina Baral, Alina |
author_sort | Pokharel, Apar |
collection | PubMed |
description | Hemangiopericytoma is a rare vascular tumor arising from pericytes and occurs very rarely in sinonasal region. A 48-year-old man with sinonasal mass presented with nasal obstruction and occasional epistaxis. Nasal endoscopy showed a readily bleeding mass in the left nasal cavity. Endoscopic removal of the mass was done. The histopathology came out to be hemangiopericytoma. The patient was kept on follow-up, and no metastasis or recurrence was seen in last 1 year. Hemangiopericytoma is a very rare vascular tumor. Surgery is the mainstay treatment of choice. A long-term follow-up is needed after surgery to rule out recurrence and metastasis. |
format | Online Article Text |
id | pubmed-10240854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-102408542023-06-06 Sinonasal hemangiopericytoma: A rare sinonasal tumor Pokharel, Apar Rai, Sabina Baral, Alina SAGE Open Med Case Rep Case Report Hemangiopericytoma is a rare vascular tumor arising from pericytes and occurs very rarely in sinonasal region. A 48-year-old man with sinonasal mass presented with nasal obstruction and occasional epistaxis. Nasal endoscopy showed a readily bleeding mass in the left nasal cavity. Endoscopic removal of the mass was done. The histopathology came out to be hemangiopericytoma. The patient was kept on follow-up, and no metastasis or recurrence was seen in last 1 year. Hemangiopericytoma is a very rare vascular tumor. Surgery is the mainstay treatment of choice. A long-term follow-up is needed after surgery to rule out recurrence and metastasis. SAGE Publications 2023-05-29 /pmc/articles/PMC10240854/ /pubmed/37284225 http://dx.doi.org/10.1177/2050313X231173787 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Pokharel, Apar Rai, Sabina Baral, Alina Sinonasal hemangiopericytoma: A rare sinonasal tumor |
title | Sinonasal hemangiopericytoma: A rare sinonasal tumor |
title_full | Sinonasal hemangiopericytoma: A rare sinonasal tumor |
title_fullStr | Sinonasal hemangiopericytoma: A rare sinonasal tumor |
title_full_unstemmed | Sinonasal hemangiopericytoma: A rare sinonasal tumor |
title_short | Sinonasal hemangiopericytoma: A rare sinonasal tumor |
title_sort | sinonasal hemangiopericytoma: a rare sinonasal tumor |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240854/ https://www.ncbi.nlm.nih.gov/pubmed/37284225 http://dx.doi.org/10.1177/2050313X231173787 |
work_keys_str_mv | AT pokharelapar sinonasalhemangiopericytomaararesinonasaltumor AT raisabina sinonasalhemangiopericytomaararesinonasaltumor AT baralalina sinonasalhemangiopericytomaararesinonasaltumor |